Personalized Sequence for Thoracic, Esophageal, and H&N Cancer
Conditions
Lung Cancer
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Intervention
Name: Genetic test
Type: Genetic
Overall Status
Recruiting
Summary
The next generation of personalized medical treatment according to the type of personal genetic information are evolving rapidly. The genome analysis needs systematic infra and database based on personal genetic information Therefore, a big data of genome-clinical information is important.
Detailed Description
To determine the feasibility of the use of tumor's molecular profiling and targeted therapies in the treatment of advanced cancer and to determine the clinical outcome(PFS, duration of response and overall survival) of patients with advanced cancer, the investigators are going to take a fresh tissue of patients and process molecular profiling.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 21 Years
Gender: Both
Criteria: Inclusion Criteria:

- metastatic, histologically confirmed NSCLC, head & Neck Cancer, Esophageal cancer

Exclusion Criteria:

-
Location
Samsung Medical Center
Seoul, Korea, Republic of
Status: Recruiting
Contact: Keunchil Park, M.D., Ph.D. - 822-3410-3450 - kpark@skku.edu
Start Date
November 2013
Completion Date
December 2017
Sponsors
Samsung Medical Center
Source
Samsung Medical Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page